Joseph P. Hagan - May 18, 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Joseph P. Hagan
Stock symbol
AUPH
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 04:07 PM
Previous filing
May 11, 2022
Next filing
Jan 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Unit Award $0 +8.73K $0.00 8.73K May 18, 2022 Common Shares 8.73K Direct F1
transaction AUPH Stock Option (right to buy) Award $0 +14.6K $0.00 14.6K May 18, 2022 Common Stock 14.6K $11.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
F2 The option vests in twelve equal monthly installments commencing on June 18, 2022.